In addition, the most recent CDC data — updated Feb. 14 — found high levels of respiratory virus activity across the U.S., with flu-related emergency department visits remaining very high, RSV-related visits at moderate levels and COVID-19 visits at low levels.
Nineteen states reported “high” respiratory virus activity: Montana, Illinois, Nebraska, Minnesota, Iowa, Arkansas, Michigan, Tennessee, Mississippi, Georgia, Florida, New York, West Virginia, Virginia, North Carolina, South Carolina, Connecticut, Massachusetts and Vermont.
Twelve states reported “very high” activity: Texas, Oklahoma, Kansas, South Dakota, Wisconsin, Kentucky, Ohio, Pennsylvania, Maryland, Delaware, New Jersey and New Hampshire.
Here are four more respiratory illness updates:
- Nearly 1.7% of all deaths nationwide were attributed to flu, compared to approximately 1.5% from COVID-19.
- Influenza test positivity rose to 31.6%, while COVID-19 test positivity was 4.8% and RSV positivity was 6.8%.
- Wastewater surveillance indicated very high levels of influenza A, high levels of COVID-19 and low levels of RSV.
- The CDC predicted influenza-related emergency visits will remain high but begin to decline in the coming weeks, while COVID-19 visits are expected to stay low.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
